130 related articles for article (PubMed ID: 37130010)
21. A preliminary investigation of circulating extracellular vesicles and biomarker discovery associated with treatment response in head and neck squamous cell carcinoma.
Rodrigues-Junior DM; Tan SS; de Souza Viana L; Carvalho AL; Lim SK; Iyer NG; Vettore AL
BMC Cancer; 2019 Apr; 19(1):373. PubMed ID: 31014274
[TBL] [Abstract][Full Text] [Related]
22. Current advances in noninvasive methods for the diagnosis of oral squamous cell carcinoma: a review.
Wang S; Yang M; Li R; Bai J
Eur J Med Res; 2023 Jan; 28(1):53. PubMed ID: 36707844
[TBL] [Abstract][Full Text] [Related]
23. Extracellular vesicles miR-210 as a potential biomarker for diagnosis and survival prediction of oral squamous cell carcinoma patients.
Bigagli E; Locatello LG; Di Stadio A; Maggiore G; Valdarnini F; Bambi F; Gallo O; Luceri C
J Oral Pathol Med; 2022 Apr; 51(4):350-357. PubMed ID: 34800057
[TBL] [Abstract][Full Text] [Related]
24. Oral Health May Affect the Performance of mRNA-Based Saliva Biomarkers for Oral Squamous Cell Cancer.
Horváth J; Szabó A; Tar I; Dezső B; Kiss C; Márton I; Scholtz B
Pathol Oncol Res; 2018 Oct; 24(4):833-842. PubMed ID: 28861772
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of CD8-to-EGFR ratio in salivary microvesicles of patients with oral squamous cell carcinoma.
Man QW; Li RF; Zhong NN; Liu B
Oral Dis; 2023 May; 29(4):1480-1486. PubMed ID: 35029008
[No Abstract] [Full Text] [Related]
26. Can we detect biomarkers of oral squamous cell carcinoma from saliva or mouth swabs?
Gaw G; Gribben M
Evid Based Dent; 2022 Mar; 23(1):32-33. PubMed ID: 35338327
[TBL] [Abstract][Full Text] [Related]
27. Immunoscoring of epidermal growth factor receptor expression in recurrent cases of oral squamous cell carcinoma.
Mehta A; Chowdhary M; Sinha R
J Oral Pathol Med; 2015 Nov; 44(10):818-22. PubMed ID: 25581523
[TBL] [Abstract][Full Text] [Related]
28. The Clinical Potential of Oral Microbiota as a Screening Tool for Oral Squamous Cell Carcinomas.
Zhou X; Hao Y; Peng X; Li B; Han Q; Ren B; Li M; Li L; Li Y; Cheng G; Li J; Ma Y; Zhou X; Cheng L
Front Cell Infect Microbiol; 2021; 11():728933. PubMed ID: 34485181
[TBL] [Abstract][Full Text] [Related]
29. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.
St John MA; Li Y; Zhou X; Denny P; Ho CM; Montemagno C; Shi W; Qi F; Wu B; Sinha U; Jordan R; Wolinsky L; Park NH; Liu H; Abemayor E; Wong DT
Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):929-35. PubMed ID: 15313862
[TBL] [Abstract][Full Text] [Related]
30. Detection of peripheral blood circulating tumor cells in oral squamous cell carcinoma and its clinical significance.
Zhang SY; Qin S; Li GH; Yi YQ; Fu HJ; Gao YJ; Sun ML
Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Oct; 39(5):591-597. PubMed ID: 34636209
[TBL] [Abstract][Full Text] [Related]
31. Current concepts and future of noninvasive procedures for diagnosing oral squamous cell carcinoma--a systematic review.
Omar E
Head Face Med; 2015 Mar; 11():6. PubMed ID: 25889859
[TBL] [Abstract][Full Text] [Related]
32. In-vivo imaging of oral squamous cell carcinoma by EGFR monoclonal antibody conjugated near-infrared quantum dots in mice.
Yang K; Zhang FJ; Tang H; Zhao C; Cao YA; Lv XQ; Chen D; Li YD
Int J Nanomedicine; 2011; 6():1739-45. PubMed ID: 21980236
[TBL] [Abstract][Full Text] [Related]
33. Increased Expression of Tissue/Salivary Transgelin mRNA Predicts Poor Prognosis in Patients with Oral Squamous Cell Carcinoma (OSCC).
Bu J; Bu X; Liu B; Chen F; Chen P
Med Sci Monit; 2015 Aug; 21():2275-81. PubMed ID: 26242444
[TBL] [Abstract][Full Text] [Related]
34. Activation of EGFR-Aurora A induces loss of primary cilia in oral squamous cell carcinoma.
Yin F; Chen Q; Shi Y; Xu H; Huang J; Qing M; Zhong L; Li J; Xie L; Zeng X
Oral Dis; 2022 Apr; 28(3):621-630. PubMed ID: 33529425
[TBL] [Abstract][Full Text] [Related]
35. HSP-enriched properties of extracellular vesicles involve survival of metastatic oral cancer cells.
Ono K; Eguchi T; Sogawa C; Calderwood SK; Futagawa J; Kasai T; Seno M; Okamoto K; Sasaki A; Kozaki KI
J Cell Biochem; 2018 Sep; 119(9):7350-7362. PubMed ID: 29768689
[TBL] [Abstract][Full Text] [Related]
36. Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation.
Rai AK; Panda M; Das AK; Rahman T; Das R; Das K; Sarma A; Kataki AC; Chattopadhyay I
Arch Microbiol; 2021 Jan; 203(1):137-152. PubMed ID: 32783067
[TBL] [Abstract][Full Text] [Related]
37. Association of salivary Cathepsin B in different histological grades among patients presenting with oral squamous cell carcinoma.
Shabbir A; Waheed H; Ahmed S; Shaikh SS; Farooqui WA
BMC Oral Health; 2022 Mar; 22(1):63. PubMed ID: 35260133
[TBL] [Abstract][Full Text] [Related]
38. Detection of survivin, carcinoembryonic antigen and ErbB2 level in oral squamous cell carcinoma patients.
Li SX; Yang YQ; Jin LJ; Cai ZG; Sun Z
Cancer Biomark; 2016; 17(4):377-382. PubMed ID: 27662323
[TBL] [Abstract][Full Text] [Related]
39. Assessment of serum synuclein-γ and squamous cell carcinoma antigen as diagnostic biomarkers in patients with oral squamous cell carcinoma and oral potentially malignant disorders.
Chen L; Luo T; Yang J; Wang K; Liu S; Wei Y; Liu H; Xu J; Zheng J; Zeng Y
J Oral Pathol Med; 2021 Feb; 50(2):165-174. PubMed ID: 33064859
[TBL] [Abstract][Full Text] [Related]
40. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
